The present invention relates to methods for treating a disease in an animal which disease is responsive to blocking of calcium activated chloride echannel (CaCC) by administering to a mammal in need thereof an effective amount of a compound defined herein (including those compounds set forth in Tables 1 2 or encomp...
The present invention relates to methods for treating a disease in an animal which disease is responsive to blocking of chloride channel by administering to a mammal in need thereof an effective amount of a compound defined herein (including those compounds set forth in Tables 1 3 or encompassed by formula I III) or...
The present invention relates to compositions and methods for treating a disease in an animal, which disease is
responsive to inhibiting of functional cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide by administering to
a mammal in need thereof an effective amount of a compound defined herein...
This invention relates to an isolated DNA sequence encoding a polypeptide having the biological activity of amorpha-4,ll-diene synthase. This DNA sequence can be used for the transformation of bacteria, yeasts and plants for the production of amorpha-4,n-diene, a specific precursor in the synthesis of artemisinin, i...
Documents
Form FC-3-161014.OCT
Copy of the general meeting resolution.-300914.PDF
Copy of amended document memorandum-300914.PDF
Optional Attachment 1-300914.PDF
Form 52-130214.PDF
Form 52-291113.PDF
Optional Attachment 3-291113.PDF
Annual accounts-291113.PDF
Optional Attachment 1-291113.PDF
Optional Attachment 2-291113.PDF
Form 52-251212.PDF
Annual accounts-251212.PDF
Optional Attachment 1-251212.PDF
Form 52-171111.PDF
Annual accounts-171111.PDF
Optional Attachment 1-171111.PDF
Form 52-100811.PDF
Optional Attachment 1-100811.PDF
Form 67 -Addendum--031110 in respect of Form 52-051010.PDF
Optional Attachment 1-031110.PDF
Form 52-051010.PDF
Annual accounts-051010.PDF
Annual accounts-010909.PDF
Form 67 -Addendum--010909 in respect of Form 52-310709.PDF